This opportunity is currently closed.
Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.
AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grants (minority researchers USA)
The AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grants is funded by the American Association for Cancer Research (AACR) together with Johnson & Johnson to support lung cancer postdoctoral researchers and clinical fellows in the USA who are from underrepresented populations in biomedical research. These groups include but are not limited to: Blacks or African Americans, Hispanics or Latinos, American Indians and Alaska Natives, Native Hawaiians, and other Pacific Islanders. Applicants must be working in the USA and non-citizen applicants must have the legal right to work in the USA for the duration of the grant. Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent). Applicants must be members of the AACR. The Grant is for 3 years and 1 year of which the recipient may work onsite at a Johnson & Johnson Enterprise Innovation facility. The Award provides 225,000 USD. Applications are due on June 1, 2022.
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.